Nurse Practitioner, Psychiatric/Mental Health · Marlton, NJ
NPI
1851757306
Since 2016
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
765 E Route 70, Building A
Marlton, NJ, 08053
Phone (917) 499-3346
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$699K
2,628 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Megan Ault prescribed most often to Medicare patients was Quetiapine Fumarate, with 160 prescriptions and refills. In total Megan Ault wrote 2,628 Medicare prescriptions that cost $699K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-01-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Quetiapine Fumarate Generic | 160 | 223 | 26 | $2,292 |
| Aripiprazole Generic | 138 | 185 | 26 | $12K |
| Hydroxyzine Hcl Generic | 122 | 145 | 25 | $3,077 |
| Trazodone Hcl Generic | 119 | 204 | 24 | $1,103 |
| Olanzapine Generic | 107 | 177 | 16 | $6,045 |
| Lurasidone Hcl Generic | 105 | 123 | 11 | $77K |
| Lorazepam Generic | 99 | 105 | 15 | $573 |
| Lamotrigine Generic | 98 | 138 | 13 | $571 |
| Alprazolam Generic | 98 | 98 | 16 | $1,188 |
| Clonazepam Generic | 90 | 92 | 16 | $296 |
| Invega Sustenna Paliperidone Palmitate | 78 | 78 | Under 11 | $200K |
| Fluoxetine Hcl Generic | 76 | 127 | 14 | $545 |
| Prazosin Hcl Generic | 74 | 122 | 13 | $2,413 |
| Lithium Carbonate Er Lithium Carbonate | 66 | 108 | 12 | $688 |
| Escitalopram Oxalate Generic | 65 | 94 | Under 11 | $308 |
Brand drugs: 148 claims; generic drugs: 2,480 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Megan Ault were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.